Metabolism of sugars: A window to the regulation of glucose and lipid homeostasis by splanchnic organs.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing physiological and mechanistic literature without systematic search criteria or original data.
PubMed 33413911 · doi:10.1016/j.clnu.2020.12.022
What was done
This is a narrative review of the literature examining the metabolic processing of dietary fructose-containing sugars across splanchnic organs, specifically focusing on small bowel enterocytes and hepatocytes.
What was found
The abstract reports no numerical data or quantitative effect sizes. Qualitatively, it describes that fructose is metabolized independently of insulin in fructolytic cells (small bowel enterocytes, hepatocytes, and renal proximal tubule cells) and causes minimal glycemic rise. At low doses, fructose is predominantly converted by the gut into glucose and organic acids, shielding the liver. Excess or chronic fructose intake bypasses intestinal clearance, stimulates hepatic de novo lipogenesis, impairs insulin-mediated suppression of hepatic glucose production, raises intrahepatic and circulating triglyceride levels, and induces enterocyte lipid accumulation.
Why it matters
It highlights that the gut serves as an initial protective barrier against hepatic fructose exposure at low intakes, providing a physiological framework for how excessive sugar consumption overburdens splanchnic organs and drives cardiometabolic dysfunction.
Limits
As a narrative review, it lacks systematic search criteria, risk-of-bias assessments, and quantitative synthesis. The abstract presents qualitative mechanistic pathways without specific intake thresholds, sample sizes, or distinction between human clinical data and animal models.
Cited by
- contradicts About 70% of ingested fructose is absorbed through the portal vein and metabolized by the liver into uric acid and triglycerides.